Marko Obradovic
About Marko Obradovic
Marko Obradovic is the Senior Director of HEOR & Market Access for Europe at Insmed Incorporated, where he has worked since 2020. He holds a PhD in Pharmacy, Biomedicine, and Health Economics from the University of Ljubljana and has extensive experience in pricing and reimbursement strategies within the healthcare sector.
Work at Insmed
Marko Obradovic has been employed at Insmed Incorporated since 2015, initially serving as Director of HEOR Europe until 2019. He currently holds the position of Senior Director HEOR & Market Access for Europe, a role he has occupied since 2020. His responsibilities include overseeing health economics and outcomes research initiatives, as well as developing pricing and reimbursement strategies within the healthcare sector. His tenure at Insmed has been marked by a focus on business development and project management.
Education and Expertise
Marko Obradovic studied at the University of Ljubljana, where he pursued a diverse academic path in Pharmacy, Biomedicine, and Health Economics. He earned both a PhD and an MPharm degree, equipping him with a strong foundation in healthcare-related disciplines. His expertise encompasses pricing and reimbursement strategies, particularly within the European healthcare market, and he demonstrates strong project management skills in health economics and market access.
Background
Before joining Insmed, Marko Obradovic held various positions in the healthcare sector. He worked as an Associate Director of Health Economics & Outcomes Research at Grünenthal from 2011 to 2013 in North Rhine-Westphalia, Germany. Following that, he served as a Senior Consultant at GfK Bridgehead from 2013 to 2015. His experience spans multiple roles that have contributed to his knowledge and skills in health economics and market access.
Achievements
Marko Obradovic has demonstrated a commercially oriented approach to managing projects throughout his career. His work in health economics and market access has been characterized by a focus on business development. He has successfully led various initiatives that align with pricing and reimbursement strategies, contributing to the overall objectives of the organizations he has worked with.